Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center Phase 2 Study of Hippocampal Avoidance in Craniospinal Irradiation for Leptomeningeal Metastases From Solid Tumors

NCT06518057 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

NCT NCT06518057
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06518057 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center Phase 2 Study of Hippocampal Avoidance in Craniospinal Irradiation for Leptomeningeal Metastases From Solid Tumors
Lead sponsor
University of Washington
Phase
Phase 2
Overall status
Recruiting
Start date
March 3, 2025
Completion date
July 1, 2028
Enrollment
22 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

anatomic stage iv breast cancer ajcc v8, metastatic breast carcinoma, metastatic lung non-small cell carcinoma, metastatic malignant neoplasm in the leptomeninges, stage iv lung cancer ajcc v8